BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30877194)

  • 1. ADS-J1 disaggregates semen-derived amyloid fibrils.
    Li J; Yang Z; Liu H; Qiu M; Zhang T; Li W; Li Z; Qi T; Qiu Y; Li L; Zhou X; Liu S; Tan S
    Biochem J; 2019 Mar; 476(6):1021-1035. PubMed ID: 30877194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
    Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
    Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
    J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection].
    Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.
    Castellano LM; Hammond RM; Holmes VM; Weissman D; Shorter J
    Biol Open; 2015 Aug; 4(9):1206-12. PubMed ID: 26319581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
    Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
    Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.
    Castellano LM; Bart SM; Holmes VM; Weissman D; Shorter J
    Chem Biol; 2015 Aug; 22(8):1074-86. PubMed ID: 26256479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.
    Chen J; Ren R; Tan S; Zhang W; Zhang X; Yu F; Xun T; Jiang S; Liu S; Li L
    PLoS One; 2015; 10(12):e0144522. PubMed ID: 26656730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
    Yu F; Lu L; Liu Q; Yu X; Wang L; He E; Zou P; Du L; Sanders RW; Liu S; Jiang S
    Biochim Biophys Acta; 2014 May; 1838(5):1296-305. PubMed ID: 24388952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection.
    Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S
    PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
    Elias AK; Scanlon D; Musgrave IF; Carver JA
    Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.
    Sheik DA; Dewhurst S; Yang J
    Acc Chem Res; 2017 Sep; 50(9):2159-2166. PubMed ID: 28809479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.
    Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S
    J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses.
    Qiu M; Li Z; Chen Y; Guo J; Xu W; Qi T; Qiu Y; Pang J; Li L; Liu S; Tan S
    Front Microbiol; 2020; 11():504. PubMed ID: 32425892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonated Compounds Bind with Prostatic Acid Phosphatase (PAP
    Zhang T; Yang H; Yang Z; Tan S; Jin J; Liu S; Zhang J
    ChemistryOpen; 2018 Jun; 7(6):447-456. PubMed ID: 29928568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI).
    Elias AK; Wilson MR; Carver JA; Musgrave IF
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Formation of Peptide/Lipid Coaggregates by the Amyloidogenic Seminal Peptide PAP
    Vane EW; He S; Maibaum L; Nath A
    Biophys J; 2020 Sep; 119(5):924-938. PubMed ID: 32814060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PSB0739 inhibits formation of semen-derived amyloid fibril].
    Lan Y; Yang Z; Liu H; Cheng H; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1338-1343. PubMed ID: 30514682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.
    French KC; Roan NR; Makhatadze GI
    Biochemistry; 2014 May; 53(20):3267-77. PubMed ID: 24811874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
    Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S
    J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.